WashU Medicine study finds new mRNA flu vaccine could reduce hospitalizations, deaths
Matt Miller/WashU MedicineWashU Medicine researchers Ali Ellebedy, PhD, (left) and Hanover Matz, PhD, have found that Moderna’s mRNA flu vaccine that is currently under review by the FDA triggers an immune response against a wide array of flu strains, potentially offering stronger and longer-lasting protection.
Source: KMOV